Improved Outcomes after Lower Limb Revascularization

Operator ability combined with improved and diverse devices for lower limb revascularization has clearly increased in the last decade. However, is this technical feasibility we did not use to have translating into better clinical outcomes for patients, or is it simply inflating our interventionist egos?

Mejorando los resultados luego de la revascularización de miembros inferiores

This study aims at answering the question above by identifying an astonishing 103934 patient population undergoing endovascular (endarterectomy) or surgical (profundaplasty or bypass) lower limb revascularization for infrainguinal peripheral artery disease between 2006 and 2015.

Major amputation and deaths within a year after procedure were registered and adjusted by age, sex, diabetes and other comorbidities, in addition to revascularization indication (Intermittent claudication, severe ischemia with tissue loss, severe ischemia with gangrene/osteomyelitis).

The risk of major amputation at one year after endovascular procedure dropped from 5.7% (2006-2007) to 3.9% (2014-2015). For surgical revascularization, risk dropped from 11.2% (2006-2007) to 6.6% (2014-2015).


Read also: Peri-Procedural Infarction in Angioplasty vs. Surgery in the Left Main Coronary Artery.


Mortality risk after both revisualization types also dropped over time. These trends were observed in all the clinical spectrum that justified revascularization indication, though the biggest benefit was in patients with severe ischemia and tissue loss or gangrene.

A curiosity observed over the years is increased morbidity, which could easily be explained by a larger proportion of patients treated at the end of their disease (sever ischemia with tissue los or gangrene) by less invasive methods.

Conclusion

These ten-year findings show an increase of survival rate and a reduction in major amputation after revascularization procedures. Outcomes have effectively improved hand in hand with experience and new devices, which justifies centralization and specialization of peripheral vascular centers.

Original Title: Improving 1-year Outcomes of Infrainguinal Limb Revascularisation: A Population-Based Cohort Study of 104 000 Patients in England.

Reference: Heikkila et al. Circulation. 2018 May 1;137(18):1921-1933.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Su opinión nos interesa. Puede dejar su comentario, reflexión, pregunta o lo que desee aquí abajo. Será más que bienvenido.

More articles by this author

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

ACC 2026 | SirPAD Trial: Sirolimus-coated balloon angioplasty in infrainguinal arterial disease

Paclitaxel-coated balloons have demonstrated improved patency in peripheral arterial disease (PAD), although questions remain regarding safety and applicability across different vascular territories. In this...

ACC 2026 | HI-PEITHO: Catheter-directed strategy (EKOS) in intermediate-risk acute pulmonary embolism

The treatment of intermediate-risk pulmonary embolism (PE) continues to be an area of therapeutic uncertainty. The initial PEITHO study (2014) demonstrated a reduction in...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...